Style | Citing Format |
---|---|
MLA | Co Rosendahl Cliff O, et al.. "A Diagnosis of Dysplastic Naevus Has No Clinical Relevance and Unnecessarily Confounds Therapeutic Decision-Making." JEADV Clinical Practice, vol. , no. , 2025, pp. -. |
APA | Co Rosendahl Cliff O, Sp Clark Simon PAUL, Skt Que Syril Keena T, D Moir DENIS, Hj Kittler Harald J, Jm Grantkels Jane MARGARET (2025). A Diagnosis of Dysplastic Naevus Has No Clinical Relevance and Unnecessarily Confounds Therapeutic Decision-Making. JEADV Clinical Practice, (), -. |
Chicago | Co Rosendahl Cliff O, Sp Clark Simon PAUL, Skt Que Syril Keena T, D Moir DENIS, Hj Kittler Harald J, Jm Grantkels Jane MARGARET. "A Diagnosis of Dysplastic Naevus Has No Clinical Relevance and Unnecessarily Confounds Therapeutic Decision-Making." JEADV Clinical Practice , no. (2025): -. |
Harvard | Co Rosendahl Cliff O et al. (2025) 'A Diagnosis of Dysplastic Naevus Has No Clinical Relevance and Unnecessarily Confounds Therapeutic Decision-Making', JEADV Clinical Practice, (), pp. -. |
Vancouver | Co Rosendahl Cliff O, Sp Clark Simon PAUL, Skt Que Syril Keena T, D Moir DENIS, Hj Kittler Harald J, Jm Grantkels Jane MARGARET. A Diagnosis of Dysplastic Naevus Has No Clinical Relevance and Unnecessarily Confounds Therapeutic Decision-Making. JEADV Clinical Practice. 2025;():-. |
BibTex | @article{ author = {Co Rosendahl Cliff O and Sp Clark Simon PAUL and Skt Que Syril Keena T and D Moir DENIS and Hj Kittler Harald J and Jm Grantkels Jane MARGARET}, title = {A Diagnosis of Dysplastic Naevus Has No Clinical Relevance and Unnecessarily Confounds Therapeutic Decision-Making}, journal = {JEADV Clinical Practice}, volume = {}, number = {}, pages = {-}, year = {2025} } |
RIS | TY - JOUR AU - Co Rosendahl Cliff O AU - Sp Clark Simon PAUL AU - Skt Que Syril Keena T AU - D Moir DENIS AU - Hj Kittler Harald J AU - Jm Grantkels Jane MARGARET TI - A Diagnosis of Dysplastic Naevus Has No Clinical Relevance and Unnecessarily Confounds Therapeutic Decision-Making JO - JEADV Clinical Practice VL - IS - SP - EP - PY - 2025 ER - |